89 related articles for article (PubMed ID: 7706182)
1. In-vitro activity of ciprofloxacin in the presence of non-antibacterial drugs.
López-Martin VR; Hurtado C; Pérez-Giraldo C; Gómez-Garcia AC
J Antimicrob Chemother; 1994 Nov; 34(5):839-40. PubMed ID: 7706182
[No Abstract] [Full Text] [Related]
2. In vitro influence of charcoal on ciprofloxacin activity.
Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F; Ohnmeiss H
Drugs Exp Clin Res; 1988; 14(5):333-4. PubMed ID: 3065019
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
Hu AX; Wang YT; You TB
Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234
[TBL] [Abstract][Full Text] [Related]
4. In-vitro study of the activity of ciprofloxacin combined with amikacin or ceftazidime against Pseudomonas aeruginosa.
Farrag NN; Bendig JW; Talboys C; Azadian BS
J Antimicrob Chemother; 1986 Dec; 18(6):770. PubMed ID: 3102448
[No Abstract] [Full Text] [Related]
5. Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.
Miglioli PA; Silini R; Carzeri O; Grabocka E; Allerberger F
Pharmacol Res; 1999 Apr; 39(4):321-3. PubMed ID: 10208763
[TBL] [Abstract][Full Text] [Related]
6. [Ciprofloxacin in combination with other antimicrobial substances].
Shah PM; Mellinghoff D; Stille W
Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
[TBL] [Abstract][Full Text] [Related]
7. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex.
Adepoju-Bello AA; Coker HA; Eboka CJ; Abioye AO; Ayoola GA
Nig Q J Hosp Med; 2008; 18(3):133-6. PubMed ID: 19062475
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of ciprofloxacin-beta-cyclodextrin complex and its efficacy in dental implants.
Aithal KS; Udupa N; Varma BR; Kurian R
Indian J Dent Res; 1995; 6(4):123-8. PubMed ID: 9495116
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity.
Ciocilteu MV; Mocanu AG; Mocanu A; Ducu C; Nicolaescu OE; Manda VC; Turcu-Stiolica A; Nicolicescu C; Melinte R; Balasoiu M; Croitoru O; Neamtu J
Acta Pharm; 2018 Jun; 68(2):129-144. PubMed ID: 29702474
[TBL] [Abstract][Full Text] [Related]
10. Interaction between ciprofloxacin and vancomycin against staphylococci.
Paton JH; Williams EW
J Antimicrob Chemother; 1987 Aug; 20(2):251-4. PubMed ID: 3667482
[TBL] [Abstract][Full Text] [Related]
11. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the antibacterial activity of ciprofloxacin against Staphylococcus aureus by 3-alkyl esters and 3-aryl esters of hexahydroquinoline derivatives.
Lak P; Amini M; Safavi M; Shafiee A; Shahverdi AR
Arzneimittelforschung; 2008; 58(9):464-8. PubMed ID: 18972877
[TBL] [Abstract][Full Text] [Related]
14. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
15. Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus.
Páez PL; Becerra MC; Albesa I
FEMS Microbiol Lett; 2010 Feb; 303(1):101-5. PubMed ID: 20030722
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.
Mascellino MT; Iona E; Iegri F; De Gregoris P; Farinelli S
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):23-8. PubMed ID: 8364519
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin].
Cavuşoğlu C; Ciçek-Saydam C; Burhanoğlu D; Ozkalay N; Ozkaya D; Ozçam H; Bilgiç A
Mikrobiyol Bul; 2002 Jan; 36(1):118-23. PubMed ID: 12476777
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
Røder BL; Gutschik E
J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of ciprofloxacin against immobilized Pseudomonas aeruginosa.
Konrad-Dalhoff I; Dalhoff A
Chemioterapia; 1987 Jun; 6(2 Suppl):137-8. PubMed ID: 3151334
[No Abstract] [Full Text] [Related]
20. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
